Browsing Health Sciences by Subject "PheroidTM"
Now showing items 1-9 of 9
-
Formulation, in vitro release and transdermal diffusion of azelaic acid with topical niacinamide
(North-West University, 2010)Acne is a common skin disease that affects the follicular unit of the skin. Inflammatory- and noninflammatory forms of acne exist. The most affected areas on the body include the face, upper part of the chest and the back. ... -
Formulation, in vitro release and transdermal diffusion of salicylic acid and topical niacinamide
(North-West University, 2009)Acne affects as many as 80% of young adults and adolescents all over the world. This detrimental condition can be classified into four stages: (a) open comedo (blackhead), (b) closed comedo (whitehead), (c) papule and (d) ... -
Formulation, in vitro release and transdermal diffusion of selected retinoids
(North-West University, 2010)Acne is a multifactorial skin disease affecting about 80 % of people aged 11 to 30. Several systemic and topical treatments are used to treat existing lesions, prevent scarring and suppress the development of new lesions. ... -
Formulation, in vitro release and transdermal diffusion of Vitamin A and Zinc for the treatment of acne
(North-West University, 2010)Acne vulgaris is the single, most common disease that presents a significant challenge to dermatologists, due to its complexity, prevalence and range of clinical expressions. This condition can be found in 85% of teenage ... -
Formulation, in-vitro release and transdermal diffusion of alpha-lipoic acid
(North-West University, 2009)Acne is a common disease characterised by follicular hyperkeratinisation, bacterial hipercolonisation as well as immune reactions and inflammation. In acne, reactive oxygen species (ROS) may be released from the damaged ... -
The impact of PheroidTM technology on the bioavailability and efficacy of anti-tuberculosis drugs in an animal model
(North-West University, 2009)Tuberculosis (TB) is a worldwide pandemic with vast challenges in the fight against the disease. Challenges include the long and tedious treatment regimens and chemotherapy with adverse side effects. One approach in ... -
Peroral and nasal delivery of insulin with PheroidTM technology
(North-West University, 2009)Since its initial discovery in 1922 by Banting and Best, the formulation of an oral insulin delivery system has ever been so troublesome. Unfortunately, insulin is indispensable in the treatment of diabetes mellitus, which ... -
PheroidTM technology for the topical application of selected cosmeceutical actives
(North-West University, 2008)Aging can be described as an extremely complex occurrence from which no organism can be excluded. Intrinsic and extrinsic aging make out the two components of skin aging and they differ on the macromolecular level while ... -
Transdermal delivery of 5-Fluorouracil with PheroidTM technology
(North-West University, 2008)5-Fluorouracil (5FU) is a pyrimidine analogue, indicated for the therapy of proliferative skin diseases such as actinic keratosis (AK), superficial basal cell carcinoma and psoriasis. It has also been used for the treatment ...